Dr. Xia Shujie (夏术阶) - Director of Urology at Shanghai General Hospital

Introduction

Dr. Xia Shujie (夏术阶) is the Director of the Department of Urology at Shanghai General Hospital (Shanghai First People's Hospital), affiliated with Shanghai Jiao Tong University School of Medicine, and one of China's most distinguished urologists. With over 30 years of specialized experience, Dr. Xia is nationally and internationally recognized as a pioneer in minimally invasive urology, urologic oncology, and laser surgery for benign prostatic hyperplasia (BPH). He is one of China's foremost experts in the surgical treatment of prostate cancer, bladder cancer, kidney cancer, and BPH, and has made landmark contributions to the development and standardization of holmium laser enucleation of the prostate (HoLEP) and other minimally invasive urologic techniques in China. His commitment to surgical innovation, clinical excellence, and patient-centered care has made Shanghai General Hospital's Department of Urology one of the leading urologic centers in China, and a trusted destination for international patients seeking expert urologic care in Shanghai.

Academic Distinctions & Leadership

• Director, Department of Urology, Shanghai General Hospital (Shanghai First People's Hospital), Shanghai Jiao Tong University School of Medicine
• Professor of Urology, Shanghai Jiao Tong University School of Medicine
• Chief Physician, Shanghai General Hospital
• Chairman, Urology Branch, Shanghai Medical Association
• Vice Chairman, Urology Branch, Chinese Medical Association
• Chairman, Laser Urology Group, Chinese Medical Association Urology Branch
• Member, European Association of Urology (EAU)
• Member, American Urological Association (AUA)
• Member, Endourological Society
• Member, International Continence Society (ICS)
• Editorial Board Member, multiple leading urology journals (Chinese and international)
• Recipient, National Science and Technology Progress Award
• Recipient, Shanghai Science and Technology Award (multiple times)
• Recipient, Chinese Medical Science and Technology Award

Specializations & Expertise

Prostate Cancer Surgery

• Robotic-assisted radical prostatectomy (RARP)
• Laparoscopic radical prostatectomy
• Open radical retropubic prostatectomy
• Nerve-sparing radical prostatectomy for potency preservation
• Extended pelvic lymph node dissection
• Salvage prostatectomy after radiation failure
• Surgery for locally advanced prostate cancer

Bladder Cancer Surgery

• Robotic-assisted radical cystectomy with urinary diversion
• Laparoscopic radical cystectomy
• Orthotopic neobladder reconstruction
• Ileal conduit urinary diversion
• Continent cutaneous urinary diversion
• Transurethral resection of bladder tumor (TURBT)
• En bloc TURBT for muscle-invasive bladder cancer
• Bladder-sparing multimodal therapy coordination

Kidney Cancer Surgery

• Robotic-assisted partial nephrectomy (nephron-sparing surgery)
• Laparoscopic partial and radical nephrectomy
• Open radical nephrectomy with vena cava thrombectomy
• Surgery for locally advanced and metastatic renal cell carcinoma
• Retroperitoneal laparoscopic nephrectomy
• Ablative therapies (RFA, cryoablation) coordination for small renal masses

Benign Prostatic Hyperplasia (BPH) Surgery

• Holmium laser enucleation of the prostate (HoLEP) — national pioneer
• Thulium laser enucleation of the prostate (ThuLEP)
• Photoselective vaporization of the prostate (PVP / GreenLight laser)
• Transurethral resection of the prostate (TURP)
• Open simple prostatectomy for very large prostates
• Robotic simple prostatectomy
• Prostatic urethral lift (UroLift) for eligible patients

Urinary Stone Surgery

• Flexible ureteroscopy with holmium laser lithotripsy
• Percutaneous nephrolithotomy (PCNL) for large kidney stones
• Mini-PCNL and ultra-mini PCNL
• Laparoscopic pyelolithotomy for complex stones
• Extracorporeal shock wave lithotripsy (ESWL) coordination

Functional Urology

• Overactive bladder and urge incontinence management
• Stress urinary incontinence surgery (mid-urethral sling)
• Neurogenic bladder management
• Urethral stricture surgery (urethroplasty, endoscopic treatment)
• Sacral neuromodulation (InterStim) for refractory bladder dysfunction
• Male incontinence surgery (artificial urinary sphincter, male sling)

Reconstructive Urology

• Urethral reconstruction and urethroplasty
• Ureteral reconstruction and reimplantation
• Vesicovaginal and ureterovaginal fistula repair
• Pyeloplasty for ureteropelvic junction (UPJ) obstruction

Clinical Excellence & Innovation

Dr. Xia has performed tens of thousands of urologic procedures throughout his distinguished career, with a particular reputation as one of China's foremost laser urologists and minimally invasive urologic surgeons. His department at Shanghai General Hospital is one of the highest-volume urology centers in Shanghai, managing the full spectrum of urologic diseases with outstanding outcomes.

Dr. Xia has pioneered several landmark innovations in urology in China:

• HoLEP Pioneer in China: One of the earliest and most experienced practitioners of holmium laser enucleation of the prostate (HoLEP) in China, helping to establish this technique as the gold standard for surgical BPH treatment. He has trained hundreds of urologists across China in HoLEP and other laser urologic techniques
• Laser Urology Leadership: As Chairman of the Laser Urology Group of the Chinese Medical Association, Dr. Xia has been the driving force behind the adoption and standardization of laser surgical techniques for BPH, urinary stones, and other urologic conditions across China
• Robotic Urology Program: Established a comprehensive robotic urology program at Shanghai General Hospital, with extensive experience in robotic radical prostatectomy, radical cystectomy, and partial nephrectomy
• Minimally Invasive Standardization: Developed and published standardized protocols for laparoscopic and robotic urologic surgery, widely adopted by urology departments across China
• Urologic Oncology Multidisciplinary Care: Built comprehensive tumor board processes integrating urology, medical oncology, radiation oncology, and radiology for prostate, bladder, and kidney cancer
• ERAS for Urology: Implemented enhanced recovery after surgery protocols for major urologic procedures, reducing hospital stay and improving patient outcomes

Research & Academic Contributions

Dr. Xia is a prolific researcher with over 300 peer-reviewed publications in leading Chinese and international urology journals. His research focuses on:

• Laser surgical techniques for BPH (HoLEP, ThuLEP, GreenLight)
• Outcomes of robotic and laparoscopic urologic surgery
• Urologic oncology — prostate, bladder, and kidney cancer
• Urinary stone disease management
• Functional urology and urinary incontinence
• Perioperative management and ERAS in urology

He has been the principal investigator on multiple National Natural Science Foundation grants and national clinical research projects. Dr. Xia regularly presents at major international conferences including the European Association of Urology (EAU) Annual Congress, the American Urological Association (AUA) Annual Meeting, and the Endourological Society World Congress.

His contributions to laser urology and minimally invasive urologic surgery have been recognized with numerous national awards, and he is one of China's most sought-after speakers and live surgery demonstrators at urology conferences and training courses.

Training & Education

As a professor at Shanghai Jiao Tong University School of Medicine and Chairman of the Laser Urology Group of the Chinese Medical Association, Dr. Xia has trained hundreds of urologists across China in HoLEP, laser urology, and minimally invasive urologic techniques. He directs one of China's premier urology fellowship programs at Shanghai General Hospital.

His national training courses in HoLEP and laser urology have been instrumental in raising the standard of BPH surgical care across China, and his trainees now lead urology departments at major hospitals throughout the country.

Hospital Affiliation

Shanghai General Hospital (Shanghai First People's Hospital)
Affiliated with Shanghai Jiao Tong University School of Medicine
100 Haining Road, Hongkou District, Shanghai 200080

Shanghai General Hospital is one of Shanghai's premier tertiary academic medical centers. The Department of Urology is one of the largest and most comprehensive in Shanghai, featuring:

• State-of-the-art robotic surgery systems (da Vinci Xi) dedicated to urologic procedures
• Advanced laser surgery suite (holmium, thulium, GreenLight lasers)
• Dedicated urologic oncology operating rooms
• Specialized urology ICU and ward
• Comprehensive urodynamics laboratory
• Advanced imaging (MRI with prostate protocol, CT, ultrasound, PSMA PET-CT)
• Multidisciplinary urologic oncology tumor board with weekly case conferences
• Dedicated prostate cancer, bladder cancer, kidney cancer, and BPH clinics
• Urinary stone center with 24/7 emergency stone management
• Functional urology and continence clinic
• International patient services with English-speaking coordinators

Patient Care Philosophy

• Patient-Centered Care: Every treatment plan is individualized based on disease characteristics, patient anatomy, functional goals, and personal circumstances
• Minimally Invasive First: Laser, laparoscopic, and robotic approaches prioritized to minimize surgical trauma, reduce recovery time, and preserve function
• Function Preservation: Nerve-sparing techniques for prostate cancer, nephron-sparing for kidney cancer, and continence-preserving approaches for BPH
• Oncologic Precision: Committed to achieving optimal cancer control while minimizing morbidity and preserving quality of life
• Multidisciplinary Collaboration: Complex oncology cases reviewed by a dedicated tumor board integrating urology, medical oncology, radiation oncology, and radiology
• Evidence-Based Practice: Treatment decisions guided by the latest international guidelines (EAU, AUA) and Dr. Xia's own research
• Transparent Communication: Clear, honest communication about diagnosis, treatment options, risks, and expected outcomes
• Quality of Life Focus: Emphasizes not just disease control but optimal urinary function, continence, and sexual function after treatment

Why Choose Dr. Xia Shujie?

• China's HoLEP Pioneer: One of the most experienced holmium laser enucleation of the prostate (HoLEP) surgeons in China, with unmatched expertise in laser BPH surgery
• National Laser Urology Leader: Chairman of the Laser Urology Group of the Chinese Medical Association — the definitive authority on laser urologic surgery in China
• Comprehensive Urologic Oncology: Expert in robotic and laparoscopic surgery for prostate, bladder, and kidney cancer
• Robotic Surgery Expertise: Extensive experience in robotic radical prostatectomy, cystectomy, and partial nephrectomy
• Functional Urology Mastery: Comprehensive management of urinary incontinence, overactive bladder, and urethral stricture
• Highest-Volume Center: One of Shanghai's busiest urology departments with extensive experience across all urologic conditions
• Cost-Effective Excellence: Urologic surgery costs in Shanghai are typically 60-75% lower than in the US or Europe
• International Patient Experience: Experienced in coordinating care for patients from overseas

Conditions Treated

Urologic Cancers

• Prostate cancer — localized, locally advanced, and high-risk
• Bladder cancer — non-muscle-invasive and muscle-invasive
• Renal cell carcinoma (kidney cancer) — all stages
• Upper tract urothelial carcinoma (renal pelvis and ureter)
• Testicular cancer (surgical management)
• Adrenal tumors (laparoscopic adrenalectomy)
• Penile cancer (surgical management)

Benign Prostatic Conditions

• Benign prostatic hyperplasia (BPH) — all sizes including very large prostates
• Lower urinary tract symptoms (LUTS)
• Acute and chronic urinary retention
• Prostatitis (chronic pelvic pain syndrome)

Urinary Stone Disease

• Kidney stones (all sizes and compositions)
• Ureteral stones
• Bladder stones
• Staghorn calculi
• Recurrent stone disease

Functional & Reconstructive Conditions

• Stress urinary incontinence (male and female)
• Overactive bladder and urge incontinence
• Neurogenic bladder
• Urethral stricture
• Ureteropelvic junction (UPJ) obstruction
• Vesicovaginal fistula
• Ureteral injuries and strictures

International Patient Services

China Medical Concierge - Shanghai (CMCS) provides comprehensive support for international patients seeking urologic care with Dr. Xia Shujie at Shanghai General Hospital.

Pre-Treatment Support

• Medical Record Review: Our team works with Shanghai General Hospital to review your PSA results, biopsy pathology, imaging, and urodynamic studies to assess diagnosis and treatment options
• Virtual Consultation: Arrange a video consultation with Dr. Xia's team to discuss your case and treatment plan
• Pre-operative Staging Workup: Coordination of comprehensive imaging including MRI prostate protocol, CT, PSMA PET-CT, and urodynamic studies
• Tumor Board Presentation: Your oncology case can be presented at the multidisciplinary urologic oncology tumor board
• Second Opinion: Expert second opinion on diagnosis, staging, and optimal treatment strategy (surgery vs. radiation vs. active surveillance)
• Cost Transparency: Detailed cost estimate including evaluation, surgery, hospitalization, and follow-up
• Visa Assistance: Guidance on obtaining medical visa and invitation letters
• Accommodation: Help finding suitable housing near Shanghai General Hospital for patient and family

During Treatment

• Professional Medical Interpretation: Experienced interpreters for all medical interactions
• Hospital Admission Support: Assistance with registration, payment, and navigation
• Family Support: Accommodation and support for accompanying family members
• Surgical Coordination: Communication with family during surgery
• ICU & Ward Support: Daily updates and interpretation during hospital stay
• Post-operative Care: Comprehensive support during recovery including catheter management and wound care
• Medication Management: Assistance with post-operative medications and pain management
• 24/7 Emergency Support: Round-the-clock assistance throughout your stay

Post-Treatment Care

• Discharge Planning: Coordination of post-discharge care and monitoring
• Medical Report Translation: Complete translation of surgical reports, pathology, and discharge summaries
• Adjuvant Therapy Coordination: Assistance with arranging adjuvant hormone therapy, radiation, or systemic therapy if recommended
• Follow-up Coordination: Arrange post-operative clinic visits and PSA/imaging surveillance
• Long-term Monitoring Plan: Clear guidance on ongoing surveillance schedule
• Complication Management: Support for any post-operative complications including continence and erectile function rehabilitation
• Telemedicine Follow-up: Virtual consultations for ongoing care after returning home
• Coordination with Home Physicians: Communication with your local urologist or oncologist
• Lifelong Support: Ongoing assistance throughout your urologic care journey

Schedule Your Consultation

If you or a loved one has been diagnosed with prostate cancer, bladder cancer, kidney cancer, BPH, urinary stones, or another urologic condition, Dr. Xia Shujie at Shanghai General Hospital offers world-class urologic surgical expertise with outcomes that rival the best centers globally, at a fraction of Western costs.

Contact China Medical Concierge - Shanghai today to:

• Request a medical record review to assess diagnosis and treatment options
• Schedule a virtual consultation with Dr. Xia's urology team
• Have your oncology case presented at the multidisciplinary urologic tumor board
• Receive a detailed treatment plan and cost estimate
• Start your journey toward expert urologic care in Shanghai

Bridging international patients with China's finest urologists — because precision, innovation, and minimally invasive expertise define world-class urologic care.